20899 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Tetrapeptides
SARS-CoV-2 epitope-targeted peptide immunostimulants
#302FAP-activated proteasome inhibitors for treating solid tumors
#303METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#304Proprotein convertase subtilisin/kexin type 1 (PCSK1) variants and uses thereof
#305USE OF ALPHA-V-INTEGRIN (CD51) INHIBITORS FOR THE TREATMENT OF CARDIAC FIBROSIS
#306Oral formulations of kappa opioid receptor agonists
#307Processes for preparing functionalized cyclooctenes
#308COMPOSITIONS AND METHODS FOR IMPROVING BRUISING AND REJUVENATING SKIN
#309HEALING COMPOSITION COMPRISING ELECTROLYZED WATER
#310METHODS OF TREATING MULTIPLE MYELOMA
#311BCL-2 inhibitors
#312METHOD FOR PRODUCING ANTIBODY-DRUG CONJUGATE
#313COMPOSITIONS AND METHODS FOR THE TREATMENT OF TRAUMATIC OPTIC NEUROPATHY
#314RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS
#315BCL-2 inhibitors
#316Linkers and conjugates
#317ANTI-TISSUE FACTOR ANTIBODY-DRUG CONJUGATES AND THEIR USE IN THE TREATMENT OF CANCER
#318COMPOUNDS COMPRISING A LINKER FOR INCREASING TRANSCYCLOOCTENE STABILITY
#319Oligosaccharide formulations of kappa opioid receptor agonists
#320COMPOSITIONS AND METHODS OF ALLEVIATING RESISTANCE TO CHEMOTHERAPY
#321Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
#322AROMATIC-CATIONIC PEPTIDES AND USES OF SAME
#323PEPTIDES FOR TREATING MUCOSA
#324Benzodiazepine derivatives
#325Methods for regulating transcription of multiple genes and expression of multiple targets
#326Compositions and methods for treating nervous system injuries
#327Antibody targeting CLDN18.2, bispecific antibody, ADC, and CAR, and applications thereof
#328ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS
#329USE OF ANTI-CD137 ANTIBODY DRUG CONJUGATE (ADC) IN ALLOGENEIC CELL THERAPY
#330Combination Therapy With LIV1-ADC and PD-1 Antagonist
#331Methods of treating myelodysplastic syndrome and acute myeloid leukemia with nonfucosylated anti-CD70 antibodies
#332Arid5a peptide inhibitors
#333Site specific antibody-drug conjugates with peptide-containing linkers
#334EGFR PROTEOLYSIS TARGETING CHIMERIC MOLECULES AND ASSOCIATED METHODS OF USE
#335Methods for treating heart disease in a subject with Friedreich's ataxia by an aromatic-cationic peptide
#336Cosmetic compositions
#337THIOL-BASED MULTIVALENT DRUG DELIVERY COMPOSITIONS
#338Linker containing arylnitro, antibody-drug conjugate containing linker and use of linker
#339PHARMACEUTICAL COMPOSITION OF KOR RECEPTOR AGONIST
#340Anti-AVB6 antibodies and antibody-drug conjugates
#341MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#342MULTIFUNCTIONAL OPIOID RECEPTOR LIGANDS AND METHODS OF TREATING PAIN
#343Toll-like receptor 4 (TLR4) inhibitors and use thereof
#344Systems and Methods for Treating an Opioid-Induced Adverse Pharmacodynamic Response
#345Drug-conjugates, conjugation methods, and uses thereof
#346METHODS FOR THE PREVENTION OR TREATMENT OF HEART FAILURE
#347COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#348COMPOSITION FOR USE IN IMPROVING ATTENTION FUNCTION AND JUDGEMENT FUNCTION
#349Stable antibody-drug conjugate, preparation method therefor, and use thereof
#350Methods for cancer therapy
#351METHOD OF TREATING CANCER BY TARGETING MYELOID-DERIVED SUPPRESSOR CELLS
#352Antimicrobial peptide stimulating cleansing composition
#353METHODS OF TREATING ALZHEIMER'S DISEASE, HUNTINGTON'S DISEASE, AUTISM, AND OTHER DISORDERS
#354Phosphorylcholine conjugates and uses thereof
#355USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
#356CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#357CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#358Methods and compositions for preventing or treating ophthalmic conditions
#359Methods for treating multiple sclerosis using antisense oligonucleotides
#360Pharmaceutical compositions for inhibiting inflammatory cytokines
#361Application of earthworm protein peptide in preparation of medicine for preventing and/or treating thrombotic disease
#362Inhibitors of metastasis
#363PEPTIDOMIMETIC INHIBITORS OF THE WDR5-MLL INTERACTION
#364USE OF A BOTULINUM TOXIN AGENT FOR TREATING PLASMA CELL DISORDERS
#365Tetramaleimide linkers and use thereof
#366Antiviral methods and compositions comprising probiotic bacterial molecules
#367Covalent heterobivalent antibody inhibitors and ligands
#368DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#369Heterocyclic acyl hydrazone linkers, methods and uses thereof
#370Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
#371Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
#372IMPROVED PEPTIDE PHARMACEUTICALS
#373BIOACTIVE GREEN-LIPPED MUSSEL EXTRACTS AND USES THEREOF
#374Antibody Formulations and Methods
#375Treatment of pyroptosis
#376Phosphorylcholine conjugates and uses thereof
#377METHODS FOR PREVENTING AND/OR TREATING BONE LOSS CONDITIONS BY MODULATING IRISIN
#378Combinatorial therapeutic systems and methods
#379Methods of treating acute depression and/or acute anxiety
#380ANTIVIRAL COMPOUNDS
#381Treatment of HMGB1-mediated inflammation
#382Methods for reducing CD36 expression
#383Alpha-hydroxy phenylacetic acid pharmacophore or bioisostere Mcl-1 protein antagonists
#384METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
#385Aromatic-cationic peptides and uses of same
#386Polypeptides having anti-senescent effects and uses thereof
#387Compositions comprising cyclic peptides derived from an A-beta peptide
#388METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
#389Methods for prevention and treatment of acute renal injury
#390METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY
#391Sunflower seed protein-derived peptides
#392Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof
#393METHODS FOR REDUCING OXIDATIVE DAMAGE
#394Arid5a peptide inhibitors
#395KRAS G12C inhibitors and methods of using the same
#396CHELATING MOLECULES
#397Remote loading of sparingly water-soluble drugs into lipid vesicles
#398TOPICAL COMPOSITIONS
#399HMGB1 antagonist treatment of severe sepsis
#400METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#401METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT NEUROPATHY
#402Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof
#403PEPTIDE COMPOSITIONS AND RELATED METHODS
#404Albumin-binding prodrugs of auristatin E derivatives
#405Cholecystokinin B receptor targeting for imaging and therapy
#406USE OF TETRASPANIN-2 FOR TREATING DIABETES AND SCREENING AN ANTI-DIABETIC AGENT
#407USE OF INHIBITORS OF IL-36 PROTEOLYTIC PROCESSING FOR THE TREATMENT AND/OR REDUCTION OF INFLAMMATION
#408COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS
#409Pegylated carfilzomib compounds
#410COMBINATION THERAPIES USING CYCLOSPORINE AND AROMATIC CATIONIC PEPTIDES
#411Methods and compositions for the prevention and treatment of disease
#412TREATMENT WITH NMDA RECEPTOR MODULATORS
#413Use of KOR agonist in combination with MOR agonist in preparing drug for treating pain
#414Materials and methods for treatment of inflammation
#415METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH
#416Compounds that inhibit Mcl-1 protein
#417HMGB1 antagonist treatment of acute lung injury
#418PEPTIDE COMPOSITIONS AND RELATED METHODS
#419HMGB1 antagonist treatment of diabetic peripheral neuropathy
#420HMGB1 antagonist
#421PHOSPHORYLCHOLINE-TUFTSIN CONJUGATE FOR TREATING OCULAR INFLAMMATION
#422Agents targeting inhibitor of apoptosis proteins
#423Methods and compositions for the prevention or treatment of Barth Syndrome
#424Treatment for skeletal diseases caused by intracellular protein trafficking defects
#425Therapeutically active compounds and their methods of use
#426NOVEL THERAPEUTIC USES OF MU-OPIATE RECEPTOR PEPTIDES
#427Drug Delivery Enhancement Agents
#428Compounds for proteasome enzyme inhibition
#429Derivatives of dolaproine-dolaisoleucine peptides
#430FAP-activated proteasome inhibitors for treating solid tumors
#431Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#432Peptides and analogs for use in the treatment of oral mucositis
#433METHODS FOR THE PREVENTION AND TREATMENT OF BURN INJURIES AND SECONDARY COMPLICATIONS
#434INHIBITORS
#435Treatment of cancer with TG02
#436Preventive and/or therapeutic agent for osteogenesis imperfecta and other diseases
#437Methods for the regulation of matrix metalloproteinase expression
#438SUSTAINED RELEASE COMPOSITIONS OF KAPPA-OPIOID RECEPTOR AGONIST
#439Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interaction
#440IMPROVED PEPTIDE PHARMACEUTICALS FOR INSULIN RESISTANCE
#441COMPOSITIONS AND METHODS OF TREATMENT OF CORNEAL ENDOTHELIUM DISORDERS
#442PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
#443SMAC mimetic
#444Modulators of melanocortin receptors for the treatment of depression and anxiety
#445Conjugate of a tubulysin analog with branched linkers
#446Allosteric modulators of the mu opioid receptor
#447Methods, compositions, and kits for detection of aspergillosis
#448Intermediate drug with synergistic anticancer activity and polyethylene glycol-coupled synergistic anticancer drug, and preparation method therefor and use thereof
#449Pharmaceutical compositions and preparations for administration to the eye
#450COMBINATION THERAPY WITH PEPTIDE EPOXYKETONES
#451METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF
#452Peptide inhibitors of tight junction permeability
#453Aromatic-cationic peptides and methods for using same
#454Detection and treatment of autoimmune disorders
#455Inhibitors of KRAS G12C and methods of using the same
#456NEW TARGET FOR TREATING CANCER
#457Methods for the prevention or treatment of heart failure
#458Cytotoxin and conjugate, uses of same and preparation method therefor
#459PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH
#460METHODS FOR PURIFYING PROTEINS HAVING A TUBULIN CARBOXYPEPTIDASE ACTIVITY AND PEPTIDIC BASED INHIBITORS THEREOF
#461Saposin-A derived peptides and uses thereof
#462Methods for Cancer Therapy
#463METHODS FOR ENHANCING SYNAPTOGENESIS AND NEURITOGENESIS
#464PEPTIDE-OLIGOUREA CHIMERIC COMPOUNDS AND METHODS OF THEIR USE
#465Systems and Methods for Treating an Opioid-Induced Adverse Pharmacodynamic Response
#466Malacidins and methods of use
#467USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
#468PROCESS FOR PREPARING INTERMEDIATE OF ANTIBODY DRUG CONJUGATE
#469Methods for the treatment of cancer metastasis
#470METHODS AND COMPOSITIONS FOR REGULATING SRCA2A EXPRESSION LEVELS IN MYOCARDIAL INFARCTION
#471Carbohydrate-based peritoneal dialysis fluid comprising glutamine residue
#472Small molecule DCN1 inhibitors and therapeutic methods using the same
#473Methods for treating glaucoma or ocular hypertension comprising delivery of prostaglandins to the vitreous humour
#474Methods for overcoming glucocorticoid resistance and for determining glucocorticoid resistance potential in cancer
#475Peptides for skin rejuvenation and methods of using the same
#476Oral formulations of kappa opioid receptor agonists
#477Methods for the treatment of glaucoma and age-related macular degeneration by a peptide D-TRP-AIB
#478LIPOPROTEIN TARGETING PROTEASE INHIBITORS AND USES
#479COMPOUNDS FOR PROTEASOME
#480ANTIVIRAL COMPOUNDS
#481Protein-drug conjugates and their use in the treatment of cancers
#482Pegylated carfilzomib compounds
#483METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS
#484KRAS G12C INHIBITORS AND METHODS OF USING THE SAME
#485Use of caspase-3 inhibitors and caspase-3 activators in the manufacture of medicament for treating cancer and wound healing
#486METHODS FOR PREVENTING OR TREATING MITOCHONDRIAL PERMEABILITY TRANSITION
#487MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
#488IMMUNOMODULATORY ANTIBODY DRUG CONJUGATES BINDING TO A HUMAN MICA POLYPEPTIDE
#489DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS
#490METHODS FOR INHIBITING NECROSIS
#491Anti-Ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof
#492PEPTIDES AND METHODS OF TREATING DYSTROPHY-RELATED DISORDERS USING THE SAME
#493METHODS FOR TREATMENT OF ATHEROSCLEROSIS
#494MALT1 inhibitors and uses thereof
#495Process for the preparation of pegylated drug-linkers and intermediates thereof
#496Methods for treating Friedreich's ataxia by an aromatic-cationic peptide to increase frataxin protein levels
#497METHODS FOR PREVENTION AND TREATMENT OF ACUTE RENAL INJURY
#498Protein Hydrogels For Treatment Of Neovascular Disease
#499Immunostimulatory method
#500Covalent heterobivalent antibody inhibitors and ligands
#501PEPTIDE THERAPEUTICS AND METHODS FOR USING SAME
#502AMHRII-BINDING COMPOUNDS FOR PREVENTING OR TREATING CANCERS
#503METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY
#504METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE
#505Agents that inhibit NGLY1 and methods of use thereof
#506Compositions comprising peptide WKDEAGKPLVK
#507Ready-to-use Carfilzomib compositions
#508METHODS OF ADMINISTRATION OF NMDA RECEPTOR AGONISTS
#509Peptides useable for treatment of disorders of the eye
#510Methods and compositions for the treatment of neuropathy and hyperalgesia
#511METHODS FOR CANCER THERAPY
#512METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY
#513Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
#514COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS
#515METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING DOMINANT OPTIC ATROPHY
#516METHODS FOR REDUCING OXIDATIVE DAMAGE
#517Antibody drug conjugates for ablating hematopoietic stem cells
#518COMPOSITIONS COMPRISING ANTI-CD38 ANTIBODIES AND CARFILZOMIB
#519CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS
#520COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS
#521Remote loading of sparingly water-soluble drugs into liposomes
#522MATERIALS AND METHODS FOR TREATMENT OF INFLAMMATION
#523Site-specific chemoenzymatic protein modifications
#524Silicon based drug conjugates and methods of using same
#525PHARMACEUTICAL ASSOCIATION OF GROWTH FACTOR RECEPTOR AGONIST AND ADHESION PROTEIN INHIBITOR FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF
#526Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof
#527Benzodiazepine derivatives
#528COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES
#529Antiviral compounds
#530STERILE INJECTABLE COMPOSITION COMPRISING CARFILZOMIB
#531METHODS FOR PREVENTING OR TREATING INSULIN RESISTANCE
#532Antibody-conjugates with improved therapeutic index for targeting CD30 tumours and method for improving therapeutic index of antibody-conjugates
#533Antibody-conjugates with improved therapeutic index for targeting HER2 tumours and method for improving therapeutic index of antibody-conjugates
#534GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES
#535USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS
#536SMAC mimetic
#537Enhancement of CD47 blockade therapy by proteasome inhibitors
#538Peptide-based proteasome inhibitors for treating conditions mediated by senescent cells and for treating cancer
#539Synthetic peptide amides
#540Methods for the effective treatment of metastatic cancer
#541PHARMACEUTICAL ASSOCIATION COMPRISING A GROWTH FACTOR RECEPTOR AGONIST CONJUGATED TO A BIOACTIVE CARRIER FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF
#542PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM KINASE INHIBITORS FOR TREATMENT OF CANCERS
#543Antibody-polymer-drug conjugates
#544METHOD OF TREATING CANCER BY TARGETING MYELOID-DERIVED SUPPRESSOR CELLS
#545COMPOUNDS FOR PROTEASOME ENZYME INHIBITION
#546NOVEL ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, COMPOSITIONS AND METHODS OF USE
#547METHODS OF TREATING ALZHEIMER'S DISEASE, HUNTINGTON'S DISEASE, AUTISM, AND OTHER DISORDERS
#548METHODS FOR PREVENTING OR TREATING METABOLIC SYNDROME
#549Methods of treating or alleviating adenylosuccinatelyase (ADSL) deficiency using spermidine or a pharmaceutically acceptable salt of spermidine
#550Cosmetic compositions
#551Increasing ATOH1 life to drive sensorineural hair cell differentiation
#552EphA5-binding antibodies and uses thereof and selection of phage-displayed accessible recombinant targeted antibodies
#553Peptide having anticancer activity, and pharmaceutical composition, health functional food composition and functional cosmetic composition for preventing and treating cancer comprising the same as active ingredient
#554ANTIBODY DRUG CONJUGATES
#555Methods for the depletion of cells
#556Combination Therapy
#557Use of cannabinoids in the treatment of multiple myeloma
#558LOW FREQUENCY GLATIRAMER ACETATE THERAPY
#559Method of enhancing a brain or cognitive function
#560Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#561Hair Loss Treatment Compositions and Methods of Making and Using Same
#562Toxic RNA inhibitors self-assembled in situ
#563PEPTIDE FOR INHIBITING BINDING OF AMYLOSPHEROIDS (ASPD), AND EVALUATION AND SCREENING METHOD
#564Peptides and pharmaceutical, nutraceutical or veterinary compositions for hair loss prevention and/or treatment
#565Stable compositions of pegylated carfilzomib compounds
#566NDMA RECEPTOR MODULATORS AND USES THEREOF
#567Charged linkers and their uses for conjugation
#568Charged linkers and their uses for conjugation
#569Charged linkers and their uses for conjugation
#570METHODS FOR CANCER THERAPY
#571Inhibitors of metastasis
#572NOVEL PEPTIDE OR SALT THEREOF, COMPOSITION FOR ENHANCING PROLIFERATION OF FIBROBLAST CELLS AND COMPOSITION FOR ENHANCING ELASTIN PRODUCTION IN FIBROBLAST CELLS AND CHONDROCYTES CONTAINING THE SAME
#573Remote loading of sparingly water-soluble drugs into liposomes
#574REMOTE LOADING OF SPARINGLY WATER-SOLUBLE DRUGS INTO LIPID VESICLES
#575ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
#576Anti-huLRRC15 antibody drug conjugates and methods for their use
#577Nanobody dimers linked via C-terminally engineered cysteins
#578Mitochondrial antiviral-signaling (MAVS) polypeptides and detection and use thereof
#579ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
#580Anti-HER2 antibody-drug conjugate and application thereof
#581Sleep apnea treatment
#582Peptide having anti-inflammatory activity, and use thereof
#583Processes for the preparation of carfilzomib or pharmaceutically acceptable salts thereof
#584Carbonic anhydrase IX inhibitor conjugates and uses thereof
#585Inhibitors of KRAS G12C and methods of using the same
#586Cholecystokinin B receptor targeting for imaging and therapy
#587GAP JUNCTION-ENHANCING AGENTS FOR TREATMENT OF NECROTIZING ENTEROCOLITIS AND INFLAMMATORY BOWEL DISEASE
#588METHODS OF TREATING DEPRESSION AND OTHER RELATED DISEASES
#589PEPTIDE COMPOSITIONS AND RELATED METHODS
#590STABLE COMPOSITIONS OF PEPTIDE EXPOXY KETONES
#591AZA-PEPTIDE ALDEHYDES AND KETONES
#592FAP-activated proteasome inhibitors for treating solid tumors
#593LOW FREQUENCY GLATIRAMER ACETATE THERAPY
#594Rapadocins, inhibitors of equilibrative nucleoside transporter 1 and uses thereof
#595Formulation for antibody and drug conjugate thereof
#596DOSING REGIMENS FOR ANTI-TF-ANTIBODY DRUG-CONJUGATES
#597Peptide analogues with branched amino acid probe(s)
#598Allosteric modulators of the mu opioid receptor
#599Therapeutically active compounds and their methods of use
#600METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF PULMONARY ARTERIAL HYPERTENSION